468 related articles for article (PubMed ID: 32717288)
1. Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice.
Du M; Wang X; Yuan L; Liu B; Mao X; Huang D; Yang L; Huang K; Zhang F; Wang Y; Luo X; Wang C; Peng J; Liang M; Huang D; Huang K
J Hepatol; 2020 Dec; 73(6):1333-1346. PubMed ID: 32717288
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
Schulien I; Hockenjos B; Schmitt-Graeff A; Perdekamp MG; Follo M; Thimme R; Hasselblatt P
Cell Death Differ; 2019 Sep; 26(9):1688-1699. PubMed ID: 30778201
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
4. Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis.
Wang Q; Zhou H; Bu Q; Wei S; Li L; Zhou J; Zhou S; Su W; Liu M; Liu Z; Wang M; Lu L
J Hepatol; 2022 Aug; 77(2):312-325. PubMed ID: 35292349
[TBL] [Abstract][Full Text] [Related]
5. Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARα/FABP1 in mice with non-alcoholic steatohepatitis.
Sun X; Yu Q; Kang B; Zhao X; Li H; Liu H; Liu L; Wang P; Cong M; Liu T
Biochem Biophys Res Commun; 2023 Jan; 641():192-199. PubMed ID: 36535078
[TBL] [Abstract][Full Text] [Related]
6. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
8. The Annexin A2-Notch regulatory loop in hepatocytes promotes liver fibrosis in NAFLD by increasing osteopontin expression.
Wang G; Duan J; Pu G; Ye C; Li Y; Xiu W; Xu J; Liu B; Zhu Y; Wang C
Biochim Biophys Acta Mol Basis Dis; 2022 Aug; 1868(8):166413. PubMed ID: 35413401
[TBL] [Abstract][Full Text] [Related]
9. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
[TBL] [Abstract][Full Text] [Related]
10. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
[TBL] [Abstract][Full Text] [Related]
12. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
[TBL] [Abstract][Full Text] [Related]
13. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.
Loyer X; Paradis V; Hénique C; Vion AC; Colnot N; Guerin CL; Devue C; On S; Scetbun J; Romain M; Paul JL; Rothenberg ME; Marcellin P; Durand F; Bedossa P; Prip-Buus C; Baugé E; Staels B; Boulanger CM; Tedgui A; Rautou PE
Gut; 2016 Nov; 65(11):1882-1894. PubMed ID: 26338827
[TBL] [Abstract][Full Text] [Related]
14. Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway.
Liao J; Xie X; Wang N; Wang Y; Zhao J; Chen F; Qu F; Wen W; Miao J; Cui H
Phytomedicine; 2024 Feb; 124():155285. PubMed ID: 38185065
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH).
Lee JH; Oh JY; Kim SH; Oh IJ; Lee YH; Lee KW; Lee WH; Kim JH
Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33050067
[TBL] [Abstract][Full Text] [Related]
17. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα.
Liang N; Damdimopoulos A; Goñi S; Huang Z; Vedin LL; Jakobsson T; Giudici M; Ahmed O; Pedrelli M; Barilla S; Alzaid F; Mendoza A; Schröder T; Kuiper R; Parini P; Hollenberg A; Lefebvre P; Francque S; Van Gaal L; Staels B; Venteclef N; Treuter E; Fan R
Nat Commun; 2019 Apr; 10(1):1684. PubMed ID: 30975991
[TBL] [Abstract][Full Text] [Related]
19. Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice.
Nan YM; Kong LB; Ren WG; Wang RQ; Du JH; Li WC; Zhao SX; Zhang YG; Wu WJ; Di HL; Li Y; Yu J
Lipids Health Dis; 2013 Feb; 12():11. PubMed ID: 23388073
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis.
Zhu C; Kim K; Wang X; Bartolome A; Salomao M; Dongiovanni P; Meroni M; Graham MJ; Yates KP; Diehl AM; Schwabe RF; Tabas I; Valenti L; Lavine JE; Pajvani UB
Sci Transl Med; 2018 Nov; 10(468):. PubMed ID: 30463916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
